Goldman Sachs Group Inc Nautilus Biotechnology, Inc. Call Options Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NAUT
# of Institutions
86Shares Held
64.3MCall Options Held
1.9KPut Options Held
100-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$39.8 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$30.7 Million0.94% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$17.5 Million0.51% of portfolio
-
Madrona Venture Group, LLC6.02MShares$14.7 Million23.0% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$9.34 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $304M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...